News|HealthBangladesh rolls out typhoid immunisation drive for 50 million childrenThe campaign aims to protect the children from the drug-resistant disease spreading across South Asia.
Bangladesh has initiated a nationwide vaccination campaign aimed at protecting millions of children from typhoid, a life-threatening illness becoming increasingly resistant to antibiotics.
Bangladesh has initiated a nationwide vaccination campaign aimed at protecting millions of children from typhoid, a life-threatening illness becoming increasingly resistant to antibiotics.
The campaign, launched on Sun, Oct 15, 2023, aims to immunize approximately 50 million children aged between nine months and 15 years with a single dose of the typhoid conjugate vaccine (TCV). This initiative is part of the government’s Expanded Programme on Immunisation (EPI) and will run until Mon, Nov 13, 2023.
The World Health Organization (WHO) has approved the vaccine, which provides protection for up to five years. The vaccine is distributed free of charge and is being administered through schools, clinics, and door-to-door visits, prioritizing urban slums and remote villages. After the campaign concludes, TCV will be integrated into the country’s regular immunization schedule.
This initiative is part of the government’s Expanded Programme on Immunisation (EPI) and will run until Mon, Nov 13, 2023.
This campaign responds to increasing concerns over drug-resistant typhoid strains spreading across South Asia. Notably, Pakistan has been dealing with a strain since 2016 that is resistant to almost all antibiotics except one. Researchers in Bangladesh have also identified ceftriaxone-resistant strains, which is concerning as ceftriaxone remains one of the last effective treatments.
Typhoid, caused by Salmonella Typhi bacteria, spreads through contaminated food and water, leading to fever, abdominal pain, and nausea. Without treatment, it can cause fatal complications. Experts emphasize that without preventive action, resistant strains could make the disease significantly harder to manage.
Supported by Gavi, the Vaccine Alliance, the campaign aims to lower infection rates and limit the spread of resistance. Officials have highlighted the vaccine’s strong safety record in neighboring countries such as Pakistan, Nepal, and regions of India like Mumbai, where no major side effects have been reported.
Based on reporting by Al Jazeera.
